Unknown OBSERVATIONAL NCT05750511

Multicenter Tissue Registry in Melanoma (TRIM)

Prospective Multicenter Translational Study to Validate Molecular Biomarkers (TMB, PD-L1) on Pre-treatment Tumor Tissue as Predictors of Therapy Outcome in Metastatic Melanoma Patients

Sponsor: Dermatologic Cooperative Oncology Group

Conditions Metastatic Melanoma

Interventions molecular tissue analysis

Updated 5 times since 2023 Last updated: Feb 28, 2023 Started: Feb 1, 2014 Primary completion: Feb 1, 2024 Completion: Feb 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Metastatic Melanoma and is currently ongoing. Dermatologic Cooperative Oncology Group leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown
Mar 2025 — Sep 2025 [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dermatologic Cooperative Oncology Group

Data source: Dermatologic Cooperative Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augsburg, Germany , Buxtehude, Germany , Dresden, Germany , Erfurt, Germany , Essen, Germany , Hanover, Germany , Homburg/Saar, Germany , Ludwigshafen, Germany , Lübeck, Germany , Mannheim, Germany and 4 more locations